What signs indicate insufficient mixing quality, and how can I monitor this inline?
Inadequate mixing quality shows up either directly in the product or indirectly through unstable process signals. For reliable inline monitoring, direct, product-near measurement methods such as NIR or Raman spectroscopy are combined with indirect process data such as torque, power consumption, temperature and flow. A single sensor signal is generally not sufficient to reliably assess the homogeneity of an entire batch; what matters is a validated measurement concept with a representative sensor position, suitable reference analytics and clearly defined acceptance criteria.
Signs in the product
An obvious sign is spatial differences in concentration of individual components. In powders, these can appear, for example, as uneven active ingredient, additive, colour or moisture content. Visible indications include colour differences, streaks, striping, specks, agglomerates, dry or over-wetted pockets, and unevenly distributed liquid fractions. In suspensions or pastes, sediment, uneven particle distribution, phase separation, undissolved agglomerates or deviating consistency can occur.
Further indications often only emerge in subsequent process steps. These include fluctuating bulk density, deviating flow behaviour, unstable dosing, segregation during discharge, uneven tablet weights, fluctuating tablet hardness, changing extrusion pressures, varying coating quality or uneven reaction control. In solid mixtures with strongly differing particle sizes, bulk densities or shapes, segregation can occur even when the mixture was initially homogeneous in the mixer. Assessment should therefore not be carried out only in the mixing chamber, but where appropriate also during discharge and at critical points in the subsequent process chain.
Process signals
Indirect process data are well suited to detecting deviations and monitoring reproducibility. These include torque, power consumption, rotational speed, product temperature, pressure, flow and, where applicable, vibration or acoustic signals. In powder and paste mixers, for example, a sudden increase in torque can indicate agglomeration, increasing cohesion, uneven wetting or a faulty raw material addition. If torque falls unexpectedly, the product structure, fill level or moisture may have changed. A stable torque value alone, however, does not yet prove chemical or material homogeneity, because different product states can produce the same mechanical signal.
Temperature profiles can provide additional indications in temperature-controlled, reactive or friction-heated processes. Local temperature differences, unusual heating rates or unstable temperature profiles can indicate insufficient mass transfer, uneven liquid distribution or unwanted reactions. In continuous plants, pressure and flow fluctuations can be used to detect dosing deviations, blockages, bridging or unstable conveying performance. Such signals are particularly valuable when assessed within a statistical process control framework using target values, trend limits and alarm strategies.
Direct inline measurement
For powder mixtures, near-infrared spectroscopy, or NIR for short, is one of the most important methods for inline or online monitoring. An NIR probe measures reflected light at a defined point in the mixer, on a process line or at the discharge. From the spectra – once a chemometric model has been built and validated – concentrations of individual components, moisture content and the time course of homogenisation can be derived. Spectral variation typically decreases during mixing and, ideally, reaches a stable level. NIR has been successfully used for real-time monitoring of the homogeneity of pharmaceutical powder mixtures; one study showed that the mixture was already homogeneous well before the usual blanket mixing time had elapsed.
Raman spectroscopy is particularly suitable when the components to be monitored have distinctive Raman signals and can be sufficiently distinguished spectrally. It can be used for the quantitative determination of individual components, such as an active ingredient, and for assessing homogeneity in real time. Studies show that Raman spectroscopy, with suitable chemometric models, can determine the mixing endpoint of powder mixtures inline. In continuous pharmaceutical processes, Raman has also been used for real-time measurement of active ingredient content and homogeneity, and for feedback control of dosing.
For liquids, suspensions, pastes and emulsions, conductivity measurement, pH value, inline viscosity, torque, ultrasound, turbidity, refractometry or optical image analysis are additionally suitable. Conductivity and pH are particularly suited to the distribution of dissolved ionic components. Turbidity, scattered light and ultrasound can support the dispersion of solids or the homogeneity of an emulsion. Inline viscosity measurement is useful for liquids, suspensions and pastes, but not as a characteristic value for the flowability of dry powders. For dry powders, cohesiveness, bulk density, flow function, moisture and particle size distribution are the more suitable product-related characteristic values.
Defining the mixing endpoint
The mixing endpoint should not be defined as a mere point in time, but as a validated process window. With spectroscopic methods, it is often checked whether the spectra or the predicted concentrations remain stable within defined limits over a set period. A common approach is the moving standard deviation of consecutive spectra, known as the moving block standard deviation. If it falls below a validated threshold and remains stable, the process can be assessed as steady. For actual homogeneity, it must additionally be demonstrated that the measured concentration corresponds to the target value.
With low-dose mixtures, the inline method must be expressly suitable for the low-concentration critical component. Otherwise, an apparently stable NIR signal may merely confirm the even distribution of the main components while the low-dose active ingredient remains unevenly distributed. The FDA points out that endpoint criteria for low-concentration components must specifically reflect their even distribution. The spectral mixing endpoint should therefore be confirmed with an independent reference method, for example a validated blend uniformity analysis.
For a robust practical solution, a graduated concept is recommended: first, several mixing times are tested as part of development trials and samples are analysed from different positions as well as across the discharge. Inline spectra and process data are recorded in parallel. A chemometric model, for example using partial least squares or principal component analysis, is then calibrated against the reference analytics. This produces clear criteria for the mixing endpoint, permissible signal variance, concentration range, alarm limits and the required hold time in the stable state. The method should also work reliably across different raw material batches, fill levels, moisture contents and operating conditions.
Making mixing quality measurable and documentable
A robust assessment of mixing quality begins with representative sampling. Characteristic values such as relative standard deviation (RSD) or coefficient of variation (CoV) are only meaningful if the samples are taken in a way that is representative of the entire batch, both spatially and over time. With batch mixers, it is therefore necessary to consider not only different positions within the mixing chamber but also the course of the batch during discharge. A mixture can be homogeneous in the mixer and still segregate again during emptying, on drop chutes, or in downstream conveying and filling systems. amixon® supports the development of a stratified sampling plan in the pilot plant together with the operator. This defines sampling locations, number of samples, distribution over time, sample quantity, analytics and acceptance criteria. It is important to consider method variance and process variance separately, so that fluctuations in sampling or analytics are not wrongly attributed to the mixing process.
Low-dead-space discharge elements and the large accessibility provided by CleverCut® inspection doors support targeted sample taking on batch mixers. The optimal sampling point depends on apparatus geometry, formulation, fill level and process step. For critical mixtures, samples should additionally be taken at the discharge and, where appropriate, at downstream transfer points. This allows a distinction to be made between insufficient homogenisation in the mixer and subsequent segregation during discharge, conveying or filling.
amixon® mixers are designed for reproducible product circulation. SinConvex® mixing tools convey the product upward near the wall, while it flows back down under gravity at the centre. With appropriate design, this three-dimensional forced restratification can produce a technically ideal random mixture. Whether this mixing quality is actually achieved across a wide fill level range of approximately 10 to 100 per cent of the usable volume, however, must be demonstrated for the specific product, the chosen apparatus design and the defined formulation. Even with a fundamentally capable mixer, low fill levels, large differences between components, cohesiveness, moisture or minor components can affect mixing time and homogeneity.
The most important form of ongoing process monitoring is, first of all, reliable adherence to the validated process parameters. Mixing time, tool rotational speed or circumferential speed, fill level, order of raw material addition, addition quantities, dosing rates, liquid addition where applicable, as well as temperature and pressure, are stored as a formulation program in the PLC. Deviations from setpoints can be detected immediately, alarmed and documented. A stable, validated parameter combination is a very effective basis for reproducible batches, but it does not automatically replace verification of the actual product composition. In particular with raw material fluctuations, low-dose components or critical formulations, mixing quality should continue to be monitored via suitable product analytics.
For a direct inline assessment of homogeneity, product-near PAT methods can be added. NIR spectroscopy is suitable for many powders, granules, moist mixtures and pastes where critical components or moisture can be captured spectrally. Raman spectroscopy, given suitable chemical signatures, can monitor the concentration of individual components and the mixing endpoint in real time. Torque, power consumption, temperature and pressure provide additional indirect process signals. They can indicate changes in product state, uneven wetting, agglomeration or dosing deviations at an early stage, but do not on their own prove chemical homogeneity. Chemometric models are used to evaluate NIR or Raman spectra; these must be calibrated against reference analytics and validated across the intended raw material and process range. NIR and Raman methods are used as PAT instruments for real-time monitoring and endpoint determination of pharmaceutical powder mixtures.
Linking with the operator's ERP system and barcode or RFID capture can extend batch documentation. Formulation, raw material identity, batch number, mixing program, operator interventions, process parameters, alarm messages, cleaning status and release information can thereby be traceably linked. This supports batch traceability, deviation management and validation in regulated environments. For GMP projects, amixon® can support DQ, IQ and OQ; automation and documentation can be aligned project-specifically with EU-GMP and FDA 21 CFR Part 11. Which requirements are met must be defined in each case in the user requirement specification and the agreed qualification concept.
Warning signals should be systematically investigated. These include fluctuating analysis results, visible segregation during discharge, noticeable colour or moisture differences, recurring batch deviations, changed bulk density, unstable dosing, or an unusual change in torque and power consumption. Such anomalies can indicate unsuitable mixing parameters, fluctuating raw materials, inadequate premixing, dosing errors, segregation after the mixer, or non-representative sampling. In the pilot plant, these causes can be specifically distinguished from one another using the original product and a defined test plan, before they lead to scrap, rework or production interruptions.
Product protection is an important system characteristic here. amixon® mixers can be operated with tool circumferential speeds of approximately 0.8 to 3.5 m/s. SinConvex® forced restratification moves the product without pronounced throwing, impact or crushing zones. This supports the homogenisation of sensitive particles, coated granules or agglomerated instant products with limited mechanical and thermal energy input. Where targeted de-agglomeration is required, cutting rotors can be switched on locally and for a limited time. The actual degree of product protection must, however, be verified for the respective particle structure and the chosen operating condition.
The constructional basis is formed by hygienically designed, easily cleanable product-contact areas. Mixing chambers welded free of crevices and ground smooth, mixing tools supported only at the top without a lower shaft passage in the product area, large CleverCut® inspection doors with OmgaSeal® seals, low-dead-space discharge elements and integrated washing lances improve accessibility, cleaning and control. This allows dry or wet cleaning procedures to be better defined and validated. Depending on the project, designs to EHEDG as well as designs taking FDA hygiene guidelines and 3-A Sanitary Standards into account are possible.